在产科护理的预后预测模型中使用的统计方法的调查:一项为期10年的横截面研究
Jing Tan1,2,3,4, Chunrong Liu1,2, Min Yang5,6
1Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Acta obstetricia et gynecologica Scandinavica
|December 23, 2023
概括
产科预后模型中的统计方法是不理想的. 这项研究确定了模型开发和验证中的关键问题,并提出了10项建议,以提高产科护理的可靠性和可信度.
科学领域:
- 产科和妇科 产科和妇科
- 生物统计学 生物统计学
- 医疗信息学 医疗信息学
背景情况:
- 预后预测模型在产科护理中至关重要.
- 严格的统计方法对于模型可靠性至关重要.
- 在产科预后建模当前的做法需要检查.
研究的目的:
- 评估产科预后模型开发和验证中的统计实践.
- 发现常见的方法缺陷.
- 为改善统计方法提供建议.
主要方法:
- 对112项 (2011-2020年) 关于产科预后模型的研究进行了横截面调查.
- 调查问卷评估模型推导,验证,性能,呈现和风险值设置中的统计问题.
- 根据调查结果和现有指导方针制定建议.
主要成果:
- 许多研究缺乏验证 (58.9%) 和适当的预测因素选择 (例如,p值,逐步回归).
- 不充分处理连续预测因素 (26.2%),非线性关系 (80.4%) 和预测因素相关性 (94.4%).
- 开发和验证数据集的比较较差 (47.1%),性能评估有限 (歧视/校准),模型呈现不清楚 (53.6%).
结论:
- 产科预后模型中的统计方法没有得到最佳利用.
- 提出了十项建议,以加强统计实践.
- 提高统计学严谨性将提高产科预后模型的可靠性.
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Statistical Methods for Analyzing Epidemiological Data
371
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
371
Comparing the Survival Analysis of Two or More Groups
195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Actuarial Approach
79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Parametric Survival Analysis: Weibull and Exponential Methods
441
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
441
Kaplan-Meier Approach
149
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
149


